Our Pricing

Understanding Wegovy: Your Complete UK Prescription Guide

Searching for a wegovy private prescription UK online? Wegovy is a once-weekly semaglutide injection licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related conditions. At Cured Pharmacy, our UK-registered clinical team provides free consultations under three minutes, with transparent pricing from £79.00 and 100% discreet packaging.

What Is Wegovy and How Does It Work?

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating [1]. By activating GLP-1 receptors in the brain, pancreas, and digestive system, Wegovy helps regulate appetite, slows gastric emptying, and improves blood sugar control—creating a multi-pathway approach to weight management.

In the landmark STEP 1 clinical trial involving 1,961 adults with obesity, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results positioned semaglutide as one of the most effective pharmacological interventions for chronic weight management currently licensed in the UK.

The medication works by reducing hunger signals and increasing feelings of fullness between meals, which may help you consume fewer calories naturally. Wegovy is not a short-term solution—it's designed for long-term weight management alongside a reduced-calorie diet and increased physical activity, subject to ongoing prescriber review.

Who Can Get a Wegovy Private Prescription UK Online?

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Your UK prescriber will assess your medical history, current medications, and weight management goals during the clinical consultation.

Certain medical conditions may make Wegovy unsuitable, including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy requiring active treatment [2]. Pregnant or breastfeeding individuals should not use Wegovy, and the medication should be discontinued at least two months before a planned pregnancy.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and the UK-registered clinical team at Cured Pharmacy review every consultation to ensure Wegovy is clinically appropriate and safe for your individual circumstances. All prescription medications require this clinical assessment before dispensing—there are no exceptions under UK pharmacy law.

Assessment Process at Cured Pharmacy

The free online consultation takes under three minutes and covers your medical history, current medications, allergies, and weight management objectives. Once submitted, a UK prescriber reviews your responses—typically within hours during working days. If approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511), and your Wegovy pens are dispensed and dispatched in discreet packaging with next-day delivery options available.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a gradual dose escalation schedule designed to minimise gastrointestinal side effects while your body adjusts to the medication [2]. You'll start with 0.25 mg once weekly for four weeks, then increase monthly through 0.5 mg, 1 mg, and 1.7 mg, reaching the maintenance dose of 2.4 mg by week 17.

Each pre-filled pen is administered subcutaneously—typically in the abdomen, thigh, or upper arm—on the same day each week. If you miss a dose and the next scheduled dose is more than two days away, take it as soon as possible. If less than two days remain, skip the missed dose and resume your regular schedule. Never double up doses to compensate.

Most patients begin noticing appetite changes within the first few weeks, though significant weight loss typically becomes apparent after reaching higher doses [1]. Your prescriber may recommend staying at a lower dose longer if you experience persistent nausea or vomiting, or discontinuing treatment if you haven't achieved at least 5% weight loss after 12 weeks on the maintenance dose, as per NICE guidance.

Managing Side Effects

The most common side effects are gastrointestinal—nausea, diarrhoea, vomiting, constipation, and abdominal pain—reported in over 10% of clinical trial participants [2]. These typically diminish as your body adapts, and eating smaller, more frequent meals while avoiding high-fat foods may help. Rare but serious side effects include pancreatitis, gallbladder problems, and hypoglycaemia when used with insulin or sulfonylureas. Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction.

Wegovy vs Saxenda: Understanding Your Weight Loss Options

Both Wegovy and Saxenda are GLP-1 receptor agonists licensed for weight management in the UK, but they differ in active ingredient, dosing frequency, and clinical efficacy. Saxenda contains liraglutide and requires daily injections at a maximum dose of 3 mg, whereas Wegovy contains semaglutide and is administered once weekly at 2.4 mg.

Head-to-head clinical data suggests semaglutide produces greater weight loss than liraglutide. In the STEP 8 trial comparing the two medications directly, participants on semaglutide 2.4 mg weekly achieved 15.8% average weight reduction versus 6.4% with liraglutide 3 mg daily over 68 weeks [3]. The once-weekly dosing of Wegovy may also improve adherence for patients who prefer fewer injections.

Your choice between treatments depends on individual factors including your response to previous weight loss attempts, tolerance of side effects, lifestyle preferences, and budget considerations. Our UK prescribers can discuss both options during your consultation to determine which medication aligns best with your clinical profile and weight management goals.

Wegovy Pricing and Transparent Costs at Cured Pharmacy

At Cured Pharmacy, Wegovy is available from £79.00 per pen with transparent upfront pricing—you'll see the exact cost before completing your clinical consultation. This pricing includes the medication, prescriber review, and discreet delivery, with no hidden fees or subscription lock-ins. We guarantee the lowest prices in the UK for genuine, MHRA-licensed medicines.

Many patients find private prescriptions more accessible than NHS provision, where Wegovy availability remains limited due to supply constraints and strict eligibility criteria managed through specialist weight management services. Private prescription gives you faster access, flexible prescriber consultations, and the ability to continue treatment without lengthy waiting lists.

Our pricing remains competitive across all dose strengths, and you'll receive the same clinical standard whether you're on the initial 0.25 mg dose or the 2.4 mg maintenance pen. Tarun Kumar and our pharmacy team are available on (+44) 116 4646009 if you have questions about costs, payment plans, or prescription queries before starting your assessment.

What's Included in Your Wegovy Prescription

Every Wegovy prescription from Cured Pharmacy includes the pre-filled injection pens, four single-use needles per pen, a patient information leaflet, and access to our UK-registered pharmacy team for ongoing support. Your medication arrives in unmarked, discreet packaging with no external pharmacy branding, and you can track your delivery in real-time once dispatched from our GPhC-registered facility.

Getting Your Wegovy Private Prescription UK Online Today

Starting your Wegovy journey at Cured Pharmacy takes three simple steps: complete the free online consultation covering your medical history and weight management goals, receive prescriber review typically within hours during working days, and get your medication dispensed and delivered discreetly to your UK address with next-day options available.

All consultations are reviewed by UK-registered prescribers who specialise in weight management and metabolic health. If Wegovy isn't clinically suitable based on your assessment, your prescriber may recommend alternative treatments or advise you to consult your GP for further evaluation—patient safety is always our priority over dispensing medication.

You'll receive ongoing prescriber support throughout your treatment, with the option to request follow-up consultations, report side effects, or adjust your prescription as your weight loss progresses. Our clinical team understands that weight management is a long-term commitment, and we're here to provide the pharmaceutical expertise and support you need to achieve sustainable results with Wegovy.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799
3. Rubino, D. M., Greenway, F. L., Khalid, U., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes are not guaranteed.